Marico Q1 FY26 revenue rose 23%; resurfacing August move to raise Plix owner stake to 60%
Marico's Q1 FY26 results, first reported in early August, showed consolidated revenue of Rs 3,259 crore, up 23.3% year on year, while net profit rose 8.2% to Rs 513 crore. India revenue grew 27.2% and international revenue 12.9%; the company also increased its fully diluted stake in Satiya Nutraceuticals, owner of Plix, to 60%.
What happened
Marico posted strong Q1 FY26 growth, led by India core portfolios, foods and digital-first businesses. It increased its stake in Plix owner Satiya
Key facts
- Q1 FY26 consolidated net profit Rs 513 crore, up 8.2% YoY from Rs 474 crore
- Revenue from operations Rs 3,259 crore, up 23.31% YoY from Rs 2,643 crore
- India revenue Rs 2,495 crore, up 27.17% YoY
- International revenue Rs 764 crore, up 12.91% YoY
- Total income Rs 3,315 crore, including Rs 56 crore other income
- Total expenses Rs 2,659 crore versus Rs 2,075 crore
- Marico increased its Satiya Nutraceuticals stake to 60% fully diluted
Why this matters
Increasing the fully diluted stake in Plix owner Satiya Nutraceuticals to 60% gives Marico greater control over a fast-growing wellness platform and reinforces its bolt-on acquisition strategy.
What to watch
- Quarterly volume growth versus price-led growth in the India business.
- Gross-margin and EBITDA-margin trend, especially relative to revenue growth.
- Copra, edible oil, crude-linked packaging and other key input-cost movements.
- Plix revenue growth, distribution expansion, profitability and evidence of integration synergies.
- International business recovery trajectory, currency effects and Bangladesh/Vietnam demand conditions.
- Rural consumption, competitive intensity and advertising-and-promotion spending.
- Accelerate Plix distribution through Marico's general trade, modern trade and e-commerce network.
- Increase cross-selling of wellness, nutrition and premium personal-care products to urban and digital-first consumers.
- Prioritize margin management through calibrated pricing, pack-price architecture and commodity hedging.
- Deploy additional marketing and innovation investment to defend share in core India franchises while scaling newer categories.
- Monitor whether Marico pursues further stake consolidation or adjacent health-and-wellness acquisitions.